Expanding Home Health Demand And Policy Support Will Unlock Value

Published
10 Sep 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
US$138.18
18.2% undervalued intrinsic discount
07 Aug
US$113.06
Loading
1Y
-12.2%
7D
-3.0%

Author's Valuation

US$138.2

18.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on30 Apr 25
Fair value Increased 14%

Shared on23 Apr 25
Fair value Decreased 10%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25
Fair value Decreased 0.42%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 3.63%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 4.52%

AnalystConsensusTarget has increased future PE multiple from 24.4x to 27.9x.